Prenatal blood tests may reveal hidden cancers in pregnant women: NIH
Abnormal prenatal blood results are indicative of hidden cancers in pregnant women, researchers at the US nation’s medical research agency, the National Institutes.
Drugs
Health
Pharma
Roche to acquire US-based Poseida Therapeutics for $1.5 billion
Switzerland’s F. Hoffmann-La Roche AG will buy US-based biopharmaceutical company Poseida Therapeutics for $1.5 billion, according to a statement from the Basel-headquartered company.
Drugs
Health
Pharma
Astellas Pharma gets US regulator’s nod for its gastric cancer drug
Astellas Pharma Inc.’s therapy to treat a form of gastric cancer got approval from the US drug regulator, according to a company statement.
Drugs
Health
Pharma
Illumina’s DNA sequencing cancer tests to check 500 genes get US nod
The US Federal Drug Administration approved Illumina Inc.’s DNA sequencing cancer tests that check more than 500 genes in a tumour to help.
Drugs
Health
Pharma
US regulator allows GSK’s endometrial cancer therapy for expanded use
The US drug regulator has granted permission for expanded use of British pharmaceutical company, GSK Plc’s endometrial cancer drug.
Drugs
Medical
Pharma
BioNTech, OncoC4 in pact to develop drug for solid tumours
BioNTech, a German immunotherapy company, announced a strategic pact with OncoC4, a private firm, to develop and commercialise a drug to treat solid tumours.
Drugs
Medical
Pharma
Pfizer to buy Seagen for $43 billion to fortify cancer portfolio
Pfizer will acquire Seagen for $43 billion to beef up its cancer portfolio, with COVID-19 vaccine sales forecast to plummet.